Revolution Medicines, Inc. Quarterly Depreciation in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Revolution Medicines, Inc. quarterly/annual Depreciation history and growth rate from Q1 2022 to Q3 2024.
  • Revolution Medicines, Inc. Depreciation for the quarter ending September 30, 2024 was $1.6M, a 23.1% increase year-over-year.
  • Revolution Medicines, Inc. Depreciation for the twelve months ending September 30, 2024 was $6.08M, a 24.6% increase year-over-year.
  • Revolution Medicines, Inc. annual Depreciation for 2023 was $5.04M, a 26.9% increase from 2022.
  • Revolution Medicines, Inc. annual Depreciation for 2022 was $3.97M, a 28.8% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $6.08M $1.6M +$300K +23.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $5.78M $1.6M +$400K +33.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $5.38M $1.54M +$335K +27.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $5.04M $1.34M +$165K +14.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $4.88M $1.3M +$300K +30% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $4.58M $1.2M +$300K +33.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $4.28M $1.21M +$305K +33.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $3.97M $1.17M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $1M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $900K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $900K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.